Compare ARK Innovation ETF (ARKK) vs Morgan Stanley (MS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Innovation ETF vs Morgan Stanley — how do they compare? ARK Innovation ETF trades at $79.8, while Morgan Stanley trades at $222.53 (market cap $350.60B). The key difference: Morgan Stanley pays a 1.8% dividend while ARK Innovation ETF pays none, and Morgan Stanley is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKK | MS | |
|---|---|---|
52-Week High | $92.50 | $227.19 |
52-Week Low | $63.52 | $139.09 |
Market Cap | — | $350.60B |
Sector | — | Financials |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARK Innovation ETF (ARKK) trades at $80.25, down 1.58% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The ETF has gained about 2% year-to-date through late June, sitting near its pivot point of $81. Recent news highlights Cathie Wood's continued stock purchases during pullbacks while the fund faces criticism for its 0.75% expense ratio and underperformance relative to broader tech markets.
The outlook remains mixed with strong technical momentum but fundamental concerns about fees and concentrated exposure to volatile innovation stocks. Key risks include Tesla's 10% weighting creating single-stock vulnerability and the fund's history of 37.88% losses over five years despite recent investor interest resurgence.
Morgan Stanley (MS) trades at $222.28, up 0.07% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with revenue growth from $57.6B in 2024 to $66.0B in 2025 and net income reaching $16.9B. Recent earnings beats and selection to lead Anthropic's IPO highlight operational strength. Technical indicators show support at $220 and resistance at $224, with RSI suggesting mild overbought conditions.
Outlook remains positive with 53.85% analyst buy ratings and $225.80 consensus price target. Key opportunities include wealth management expansion and AI integration, while risks involve volatile cash flows and rising debt-to-asset ratios. The stock offers potential upside but requires monitoring of financial leverage and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Innovation ETF
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
